IMAX/$IMAX
1D1W1MYTD1Y5YMAX
Capital at risk
About IMAX
Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.
- Ticker
- $IMAX
- Sector
- Consumer Discretionary
- Primary listing
- NYSE
- Employees
- 679
- Headquarters
- Mississauga, Canada
- Website
- www.imax.com
IMAX Metrics
BasicAdvanced
$3.1B
76.91
$0.73
0.40
-
Price and volume
Market cap
$3.1B
Beta
0.4
52-week high
$56.68
52-week low
$30.74
Average daily volume
984K
Financial strength
Current ratio
4.264
Quick ratio
3.796
Long term debt to equity
0.627
Total debt to equity
0.627
Interest coverage (TTM)
12.69%
Profitability
EBITDA (TTM)
138.217
Gross margin (TTM)
59.73%
Net profit margin (TTM)
9.84%
Operating margin (TTM)
22.84%
Effective tax rate (TTM)
24.40%
Revenue per employee (TTM)
$610,000
Management effectiveness
Return on assets (TTM)
6.65%
Return on equity (TTM)
11.02%
Valuation
Price to earnings (TTM)
76.91
Price to revenue (TTM)
7.299
Price to book
8.64
Price to tangible book (TTM)
10.97
Price to free cash flow (TTM)
30.367
Free cash flow yield (TTM)
3.29%
Free cash flow per share (TTM)
1.846
Growth
Revenue change (TTM)
14.79%
Earnings per share change (TTM)
21.99%
3-year revenue growth (CAGR)
5.76%
10-year revenue growth (CAGR)
0.71%
3-year earnings per share growth (CAGR)
107.66%
10-year earnings per share growth (CAGR)
0.51%
What the Analysts think about IMAX
Analyst ratings (Buy, Hold, Sell) for IMAX stock.
Analyst projections of the future price of IMAX stock.
Bulls say / Bears say
IMAX’s Q2 showed strong operating leverage: revenue rose 12% year-on-year, adjusted EPS rose 65%, and adjusted EBITDA margin reached 46.6%. Operating cash flow was also up 19% in the first half. (Nasdaq)
Demand for premium large-format cinema is accelerating. IMAX reported a record $728 million summer box office, up 73% on the previous record, and expects full-year global box office of $1.4 billion. (IMAX)
The network still has substantial expansion potential: management puts its addressable market at about 4,500 locations versus 1,800 currently, with roughly 500 systems in backlog. A ten-location Hoyts agreement also nearly doubles IMAX’s Australian footprint over the coming years. (StockAnalysis, IMAX)
Greater China remains a material weakness. IMAX China reported first-half revenue of $34.4 million, down from $57.8 million, while net profit fell to $8.1 million from $23.9 million. (Longbridge)
Results remain dependent on a small number of blockbuster films. Global box office fell 13% year-on-year in Q1 when the prior year’s exceptional Ne Zha 2 comparison dropped out, showing how uneven performance can be between release cycles. (IMAX, The Hollywood Reporter)
The shares appear to leave little margin for disappointment after rising almost 80% over 12 months. A recent valuation review put IMAX on roughly 69 times earnings versus about 20 times for the entertainment industry, making the price sensitive to any slowdown in growth or margins. (Los Angeles Times, Simply Wall St)
Data summarised monthly by Lightyear AI. Last updated on 25 Sept 2026.
IMAX Financial Performance
Revenues and expenses
IMAX Earnings Performance
Company profitability
Upcoming events
No upcoming events
IMAX News
AllArticlesVideos
Funds containing IMAX
AllEURGBPUSD
Fund name | Fund size | $IMAX weighting |
|---|---|---|
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.10% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | £2.4B | 0.10% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.09% |
iShares MSCI World Small Cap$WSML | $9B | 0.03% |
iShares MSCI World Small Cap€IUSN | €7.8B | 0.03% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.